Literature DB >> 33454722

IFN-γ surmounts PD-L1/PD1 inhibition to CAR-T cell therapy by upregulating ICAM-1 on tumor cells.

E Dong1, Xiao-Zhu Yue1, Lin Shui1, Bin-Rui Liu1, Qi-Qi Li1, Yun Yang1, Hui Luo1, Wei Wang2, Han-Shuo Yang3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33454722      PMCID： PMC7811529          DOI： 10.1038/s41392-020-00357-7

Source DB:  PubMed          Journal:  Signal Transduct Target Ther        ISSN： 2059-3635


× No keyword cloud information.
  6 in total

1.  Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.

Authors:  Jesse M Zaretsky; Angel Garcia-Diaz; Daniel S Shin; Helena Escuin-Ordinas; Willy Hugo; Siwen Hu-Lieskovan; Davis Y Torrejon; Gabriel Abril-Rodriguez; Salemiz Sandoval; Lucas Barthly; Justin Saco; Blanca Homet Moreno; Riccardo Mezzadra; Bartosz Chmielowski; Kathleen Ruchalski; I Peter Shintaku; Phillip J Sanchez; Cristina Puig-Saus; Grace Cherry; Elizabeth Seja; Xiangju Kong; Jia Pang; Beata Berent-Maoz; Begoña Comin-Anduix; Thomas G Graeber; Paul C Tumeh; Ton N M Schumacher; Roger S Lo; Antoni Ribas
Journal:  N Engl J Med       Date:  2016-07-13       Impact factor: 91.245

2.  Surface expression of the IFN-gamma R2 chain is regulated by intracellular trafficking in human T lymphocytes.

Authors:  L Rigamonti; S Ariotti; G Losana; R Gradini; M A Russo; E Jouanguy; J L Casanova; G Forni; F Novelli
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

3.  Intercellular adhesion molecule-1-dependent stable interactions between T cells and dendritic cells determine CD8+ T cell memory.

Authors:  Alix Scholer; Stéphanie Hugues; Alexandre Boissonnas; Luc Fetler; Sebastian Amigorena
Journal:  Immunity       Date:  2008-02       Impact factor: 31.745

Review 4.  Driving CAR T-cells forward.

Authors:  Hollie J Jackson; Sarwish Rafiq; Renier J Brentjens
Journal:  Nat Rev Clin Oncol       Date:  2016-03-22       Impact factor: 66.675

Review 5.  Engineering CAR-T Cells for Improved Function Against Solid Tumors.

Authors:  Michael A Morgan; Axel Schambach
Journal:  Front Immunol       Date:  2018-10-29       Impact factor: 7.561

6.  Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression.

Authors:  Angel Garcia-Diaz; Daniel Sanghoon Shin; Blanca Homet Moreno; Justin Saco; Helena Escuin-Ordinas; Gabriel Abril Rodriguez; Jesse M Zaretsky; Lu Sun; Willy Hugo; Xiaoyan Wang; Giulia Parisi; Cristina Puig Saus; Davis Y Torrejon; Thomas G Graeber; Begonya Comin-Anduix; Siwen Hu-Lieskovan; Robert Damoiseaux; Roger S Lo; Antoni Ribas
Journal:  Cell Rep       Date:  2017-05-09       Impact factor: 9.423
  6 in total
  4 in total

Review 1.  Overcome tumor relapse in CAR T cell therapy.

Authors:  Cheng-Dong Huo; Jie Yang; Yan-Mei Gu; Dai-Jun Wang; Xiao-Xia Zhang; Yu-Min Li
Journal:  Clin Transl Oncol       Date:  2022-06-09       Impact factor: 3.340

2.  Potential Role of IFNγ Inhibition in Refractory Cytokine Release Syndrome Associated with CAR T-cell Therapy.

Authors:  Kevin O McNerney; Amanda M DiNofia; David T Teachey; Stephan A Grupp; Shannon L Maude
Journal:  Blood Cancer Discov       Date:  2022-03-01

Review 3.  New insights into CAR T cell-mediated killing of tumor cells.

Authors:  David Espie; Emmanuel Donnadieu
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

4.  Prognostic value of CD247 in patients with head and neck squamous cell carcinoma: bioinformatic analysis of TCGA database.

Authors:  Peng Lin; Xiao-Li Hu; Yuan-Yuan Hu; Mai-Ying Liu; Qian-Yu Wang; Yan Ding; Jia-Cai Ye
Journal:  Ann Transl Med       Date:  2022-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.